CDIOW
Cardio Diagnostics Holdings, Inc.
Key Financials
Operating Income
$-6484078
↑ 22.5%
Net Income
$-6498167
↑ 22.5%
Revenue
$14825
↓ 57.5%
EPS (Diluted)
$-3.71
↓ 1096.8%
Total Liabilities
$793061.00
↓ 25.0%
Shareholders' Equity
$7.0M
↓ 27.0%
Cash & Equivalents
$0.00
NaN%
Total Assets
$7.8M
↓ 26.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 10-K | 3/13/2026 | View on SEC |
| 8-K | 2/19/2026 | View on SEC |
| 4 | 1/6/2026 | View on SEC |
| 4 | 1/6/2026 | View on SEC |
| 4 | 1/6/2026 | View on SEC |
| 4 | 1/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CDIOW |
| Company Name | Cardio Diagnostics Holdings, Inc. |
| CIK | 1870144 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 855-226-9991 |